ECOG PCO-RL: E4508: Three-Arm Randomized Phase II Study of Carboplatin and Paclitaxel in Combination with Cetuximab, IMC-A12 or Both for Advanced Non-small Cell Lung Cancer Patients Who Will Not Receive Bevacizumab-based Therapy